Schizophrenia Research
Volume 67, Issue 1 , Pages 53-62 , 1 March 2004

Meta-analysis of association between the T102C polymorphism of the 5HT2a receptor gene and schizophrenia

  • Hamid Mostafavi Abdolmaleky

      Affiliations

    • Department of Psychiatry, Harvard Medical School, Massachusetts Mental Health Center, Boston, MA, USA
    • Harvard Institute of Psychiatric Epidemiology and Genetics, Boston, MA, USA
    • Department of Psychiatry, Tehran Institute of Psychiatry, Iran University of Medical Sciences, Tehran, Iran
  • ,
  • Stephen V Faraone

      Affiliations

    • Department of Psychiatry, Harvard Medical School, Massachusetts Mental Health Center, Boston, MA, USA
    • Harvard Institute of Psychiatric Epidemiology and Genetics, Boston, MA, USA
    • Department of Psychiatry, Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA
  • ,
  • Stephen J Glatt

      Affiliations

    • Department of Psychiatry, Harvard Medical School, Massachusetts Mental Health Center, Boston, MA, USA
    • Harvard Institute of Psychiatric Epidemiology and Genetics, Boston, MA, USA
  • ,
  • Ming T Tsuang

      Affiliations

    • Corresponding Author InformationCorresponding author. Department of Psychiatry, Harvard Medical School, Massachusetts Mental Health Center, 74 Fenwood Road, Boston, MA 02115, USA. Tel.: +1-617-734-6546; fax: +1-617-734-7915.
    • Department of Psychiatry, Harvard Medical School, Massachusetts Mental Health Center, Boston, MA, USA
    • Harvard Institute of Psychiatric Epidemiology and Genetics, Boston, MA, USA
    • Department of Psychiatry, Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA
    • Psychiatry Service, Brockton-West Roxbury Veterans Affairs Medical Center, Brockton, MA, USA
    • Department of Epidemiology, Harvard School of Public Health, Boston, MA, USA

Received 3 December 2002 ,Revised 28 May 2003 ,Accepted 29 May 2003.

References 

  1. Araga US, Narasu ML. Association between the 102T/C polymorphism of serotonin-2A receptor gene and schizophrenia among south Indians. Mol. Psychiatry. 2002;7:540–541
  2. Arias B, Gasto C, Catalan R, Gutierrez B, Pintor L, Fananas L. The 5-HT(2A) receptor gene 102T/C polymorphism is associated with suicidal behavior in depressed patients. Am. J. Med. Genet. 2001;105:801–804
  3. Arias B, Gutierrez B, Pintor L, Gasto C, Fananas L. Variability in the 5-HT(2A) receptor gene is associated with seasonal pattern in major depression. Mol. Psychiatry. 2001;6:239–242
  4. Arranz MJ, Collier DA, Munro J, Sham P, Kirov G, Sodhi M, et al. Analysis of a structural polymorphism in the 5-HT2A receptor and clinical response to clozapine. Neurosci. Lett. 1996;217:177–178
  5. Attwood JT, Yung RL, Richardson BC. DNA methylation and the regulation of gene transcription. Cell. Mol. Life Sci. 2002;59:241–257
  6. Badner JA, Gershon ES. Meta-analysis of whole-genome linkage scans of bipolar disorder and schizophrenia. Mol. Psychiatry. 2002;7:405–411
  7. Bird A. DNA methylation patterns and epigenetic memory. Genes Dev. 2002;16:6–21
  8. Bondy B, Kuznik J, Baghai T, Schule CPZ, Minov C, et al.  Lack of association of serotonin-2A receptor gene polymorphism (T102C) with suicidal ideation and suicide. Am. J. Med. Genet. 2000;96:831–835
  9. Bunzel R, Blumcke I, Cichon S, Normann S, Schramm J, Propping P, et al. Polymorphic imprinting of the serotonin-2A (5-HT2A) receptor gene in human adult brain. Brain Res., Mol. Brain Res. 1998;59:90–92
  10. Cargill M, Altshuler D, Ireland J, Sklar P, Ardlie K, Patil N, et al. Characterization of single-nucleotide polymorphisms in coding regions of human genes. Nat. Genet. 1999;22:231–238
  11. Chen CH, Lee YR, Wei FC, Koong FJ, Hwu HG, Hsiao KJ. Lack of allelic association between 102T/C polymorphism of serotonin receptor type 2A gene and schizophrenia in Chinese. Psychiatr. Genet. 1997;7:35–38
  12. Chen RY, Sham P, Chen EY, Li T, Cheung EF, Hui TC, et al. No association between T102C polymorphism of serotonin-2A receptor gene and clinical phenotypes of Chinese schizophrenic patients. Psychiatry Res. 2001;105:175–185
  13. Chen Y, Sharma RP, Costa RH, Costa E, Grayson DR. On the epigenetic regulation of the human reelin promoter. Nucleic Acids Res. 2002;30:2930–2939
  14. Clifford CP, Nunez DJ. 5HT 2a receptor T102C polymorphism and schizophrenia. Lancet. 1996;347:1830
  15. Cooper DN, Youssoufian H. The CpG dinucleotide and human genetic disease. Hum. Genet. 1988;78:151–155
  16. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control. Clin. Trials. 1986;7:177–188
  17. Du L, Faludi G, Palkovits M, Bakish D, Hrdina PD. Serotonergic genes and suicidality. Crisis. 2001;22:54–60
  18. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–634
  19. Erdmann J, Shimron-Abarbanell D, Rietschel M, Albus M, Maier W, Korner J, et al. Systematic screening for mutations in the human serotonin-2A (5-HT2A) receptor gene: identification of two naturally occurring receptor variants and association analysis in schizophrenia. Hum. Genet. 1996;97:614–619
  20. Golimbet VE, Manandian KK, Abramova LI, Orlova VA, Kaleda VG, Oleichik IV, et al. Serotonin receptor gene allele polymorphism (5HTR2A) and clinical pathogenetic characteristics in patients with schizophrenia and schizophrenia spectrum disorders. Z. Nevropathol. Psihiatr. S.S. Korsakova. 2000;100:36–39
  21. Golimbet VE, Alfimova MV, Manandyan KK, Mitushina NG, Abramova LI, Kaleda VG, et al. 5HTR2A gene polymorphism and personality traits in patients with major psychoses. Eur. Psychiatr. 2002;17:24–28
  22. Gross-Isseroff R, Israeli M, Biegon A. Autoradiographic analysis of tritiated imipramine binding in the human brain post mortem: effects of suicide. Arch. Gen. Psychiatry. 1989;46:237–241
  23. Hawi Z, Myakishev MV, Straub RE, O'Neill A, Kendler KS, Walsh D, et al. No association or linkage between the 5-HT2a/T102C polymorphism and schizophrenia in Irish families. Am. J. Med. Genet. (Neuropsychiat. Genet.). 1997;74:370–373
  24. He L, Li T, Melville C, Liu S, Feng GY, Gu NF, et al. 102T/C polymorphism of serotonin receptor type 2A gene is not associated with schizophrenia in either Chinese or British populations. Am. J. Med. Genet. 1999;88:95–98
  25. Holmes C, Arranz MJ, Powell JF, Collier DA, Lovestone S. 5-HT2A and 5-HT2C receptor polymorphisms and psychopathology in late onset Alzheimer's disease. Hum. Mol. Genet. 1998;7:1507–1509
  26. Huang Y, Liu X, Li T, Guo L, Sun X, Xiao X, et al. Cases-Control association study and transmission disequilibrium test of T102C polymorphism in 5HT2A and Tourette syndrome. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2001;18:11–13
  27. Hwu HG, Chen CH. Association of 5HT2A receptor gene polymorphism and alcohol abuse with behavior problems. Am. J. Med. Genet. 2000;96:797–800
  28. Inayama Y, Yoneda H, Sakai T, Ishida T, Nonomura Y, Kono Y, et al. Positive association between a DNA sequence variant in the serotonin 2A receptor gene and schizophrenia. Am. J. Med. Genet. 1996;67:103–105
  29. Ishigaki T, Xie DW, Liu JC, Nakamura Y, Zhang HY, Tani K, et al. Intact 5-HT2A receptor exons and the adjoining intron regions in schizophrenia. Neuropsychopharmacology. 1996;14:339–347
  30. Jonsson E, Nothen MM, Bunzel R, Propping P, Sedvall G. 5HT 2a receptor T102C polymorphism and schizophrenia. Lancet. 1996;347:1831
  31. Joober R, Benkelfat C, Brisebois K, Toulouse A, Turecki G, Lal S, et al. T102C polymorphism in the 5HT2A gene and schizophrenia: relation to phenotype and drug response variability. J. Psychiatry Neurosci. 1999;24:141–146
  32. Kim YK, Lee MS, Kwak DI. No association between schizophrenia and serotonin receptor type 2A gene in Korea. Psychiatr. Genet. 1999;9:47–49
  33. Knapp M, Seuchter SA, Baur MP. The haplotype-relative-risk (HRR) method for analysis of association in nuclear families. Am. J. Hum. Genet. 1993;52:1085–1093
  34. Lewis CM. Genetic association studies: design, analysis and interpretation. Brief Bioinform. 2002;3:146–153
  35. Lin CH, Tsai SJ, Yu YW, Song HL, Tu PC, Sim CB, et al. No evidence for association of serotonin-2A receptor variant (102T/C) with schizophrenia or clozapine response in a Chinese population. NeuroReport. 1999;10:57–60
  36. Liolitsa D, Powell JF, Prince M, Lovestone S. Association study of the 5-HT(2A) receptor gene polymorphism, T102C and essential hypertension. J. Hum. Hypertens. 2001;15:335–339
  37. Malhotra AK, Goldman D, Buchanan R, Breier A, Pickar D. 5HT 2a receptor T102C polymorphism and schizophrenia. Lancet. 1996;347:1830–1831
  38. Nacmias B, Ricca V, Tedde A, Mezzani B, Rotella CM, Sorbi S. 5-HT2A receptor gene polymorphisms in anorexia nervosa and bulimia nervosa. Neurosci. Lett. 1999;277:134–136
  39. Ngo V, Gourdji D, Laverriere JN. Site-specific methylation of the rat prolactin and growth hormone promoters correlates with gene expression. Mol. Cell. Biol. 1996;16:3245–3254
  40. Nimgaonkar VL, Zhang XR, Brar JS, DeLeo M, Ganguli R. 5-HT2 receptor gene locus: association with schizophrenia or treatment response not detected. Psychiatr. Genet. 1996;6:23–27
  41. Nocjar C, Roth BL, Pehek EA. Localization of 5-HT(2A) receptors on dopamine cells in subnuclei of the midbrain A10 cell group. Neuroscience. 2002;111:163–176
  42. Ohara K, Nagai M, Tani K, Tsukamoto T. Schizophrenia and the serotonin-2A receptor promoter polymorphism. Psychiatry Res. 1999;85:221–224
  43. Orwin RG, Cordray DS. Effects of deficient reporting on meta-analysis: a conceptual framework and reanalysis. Psychol. Bull. 1985;97:134–147
  44. Pandey GN. Altered serotonin function in suicide. Evidence from platelet and neuroendocrine studies. Ann. N.Y. Acad. Sci. 1997;836:182–200
  45. Petronis A. The genes for major psychosis: aberrant sequence or regulation?. Neuropsychopharmacology. 2000;23:1–12
  46. Polesskaya OO, Sokolov BP. Differential expression of the “C” and “T” alleles of the 5-HT2A receptor gene in the temporal cortex of normal individuals and schizophrenics. J. Neurosci. Res. 2002;67:812–822
  47. In:  Saddock B,  Saddock V editor. Kaplan and Sadock's Comprehensive Textbook of Psychiatry. vol. 1:Philadelphia: Lippincott Williams & Wilkins; 2000;
  48. Sasaki T, Hattori M, Fukuda R, Kunugi H, Nanko S. 5HT 2a receptor T102C polymorphism and schizophrenia. Lancet. 1996;347:1832
  49. Segman RH, Heresco-Levy U, Finkel B, Goltser T, Shalem R, Schlafman M, et al. Association between the serotonin 2A receptor gene and tardive dyskinesia in chronic schizophrenia. Mol. Psychiatry. 2001;6:225–229
  50. Semwal P, Prasad S, Bhatia T, Deshpande SN, Wood J, Nimgaonkar VL, et al. Family-based association studies of monoaminergic gene polymorphisms among North Indians with schizophrenia. Mol. Psychiatry. 2001;6:220–224
  51. Serretti A, Cusin C, Lorenzi C, Lattuada E, Lilli R, Smeraldi E. Serotonin-2A receptor gene is not associated with symptomatology of schizophrenia. Am. J. Med. Genet. 2000;96:84–87
  52. Shinkai T, Ohmori O, Kojima H, Terao T, Suzuki T, Abe K. Negative association between T102C polymorphism of the 5-HT2a receptor gene and schizophrenia in Japan. Hum. Hered. 1998;48:212–215
  53. Singal R, Ginder GD. DNA methylation. Blood. 1999;93:4059–4070
  54. Spurlock G, Heils A, Holmans P, Williams J, D'Souza UM, Cardno A, et al. A family based association study of T102C polymorphism in 5HT2A and schizophrenia plus identification of new polymorphisms in the promoter. Mol. Psychiatry. 1998;3:42–49
  55. Tan EC, Chong SA, Mahendran R, Dong F, Tan CH. Susceptibility to neuroleptic-induced tardive dyskinesia and the T102C polymorphism in the serotonin type 2A receptor. Biol. Psychiatry. 2001;50:144–147
  56. Tan EC, Chong SA, Chan AO, Tan CH. No evidence for association of the T102C polymorphism in the serotonin type 2A receptor with suicidal behavior in schizophrenia. Am. J. Med. Genet. 2002;114:321–322
  57. Tay AH, Lim LC, Lee WL, Wong KE, Wong LY, Tsoi WF. Association between allele 1 of T102C polymorphism, 5-hydroxytryptamine 2a receptor gene and schizophrenia in Chinese males in Singapore. Hum. Hered. 1997;47:298–300
  58. Verga M, Macciardi F, Cohen S, Pedrini S, Smeraldi E. No association between schizophrenia and the serotonin receptor 5HTR2a in an Italian population. Am. J. Med. Genet. 1997;74:21–25
  59. Virgos C, Martorell L, Valero J, Figuera L, Civeira F, Joven J, et al. Association study of schizophrenia with polymorphisms at six candidate genes. Schizophr. Res. 2001;49:65–71
  60. Wang GL, Moore ML, McMillin JB. A region in the first exon/intron of rat carnitine palmitoyltransferase Ibeta is involved in enhancement of basal transcription. Biochem. J. 2002;362:609–618
  61. Warren JT, Peacock ML, Rodriguez LC, Fink JK. An MspI polymorphism in the hyman serotonin receptor gene (HTR2): detection by DGGE and RFLP analysis. Hum. Mol. Genet. 1993;2:338
  62. Watson RE, Goodman JI. Epigenetics and DNA methylation come of age in toxicology. Toxicol. Sci. 2002;67:11–16
  63. Williams J, Spurlock G, McGuffin P, Mallet J, Nothen MM, Gill M, et al. Association between schizophrenia and T102C polymorphism of the 5-hydroxytryptamine type 2a-receptor gene. European Multicentre Association Study of Schizophrenia (EMASS) Group. Lancet. 1996;347:1294–1296
  64. Williams J, McGuffin P, Nothen M, Owen MJ. Meta-analysis of association between the 5-HT2a receptor T102C polymorphism and schizophrenia. EMASS Collaborative Group. European Multicentre Association Study of Schizophrenia. Lancet. 1997;349:1221
  65. Woolf B. On estimating the relation between blood group and disease. Ann. Hum. Genet. 1955;19:251–253
  66. Yoshihara E, Nakamura K, Itoh M, Ameno K, Takeuchi Y, Ijiri I, et al. The human serotonin receptor gene (HTR2) MspI polymorphism in Japanese schizophrenic and alcoholic patients. Neuropsychobiology. 2000;41:124–126
  67. Yu YW, Tsai SJ, Yang KH, Lin CH, Chen MC, Hong CJ. Evidence for an association between polymorphism in the serotonin-2A receptor variant (102T/C) and increment of N100 amplitude in schizophrenics treated with clozapine. Neuropsychobiology. 2001;43:79–82

PII: S0920-9964(03)00183-X

doi: 10.1016/S0920-9964(03)00183-X

Schizophrenia Research
Volume 67, Issue 1 , Pages 53-62 , 1 March 2004